Image

Intervention For AYAS With Cancer Risk Syndromes

Clinical trial for young adults with genetic cancer risks.

Recruiting
12-24 years
All
Phase N/A
  • Simplified description (AI rewritten)
  • Technical description (Original)

This study aims to improve how young people with cancer risk syndromes communicate and make decisions about their health. Cancer risk syndromes, like Lynch Syndrome, happen when certain genetic changes increase the chance of getting cancer. The study will test a tool named AYA-RISE to help adolescents and young adults (ages 12-24) understand and manage these risks better. Participants will use an online portal and chatbot to get information.

  • Participation: Involves using AYA-RISE, completing surveys, and interviews.
  • Eligibility: Ages 12-24, diagnosed with a cancer risk syndrome, and English-speaking.
  • Study Groups: Some participants will receive standard care, while others will use AYA-RISE.

Eligible participants include patients, their families, and healthcare providers who will provide feedback on the tool's effectiveness. The study is divided into three parts: testing the tool's format, a trial comparing standard care to the tool, and interviews to gather detailed feedback. This study hopes to offer better support and options for young people facing these health challenges.

Print
Study details
    Cancer Risk Syndrome

NCT04323774

Dana-Farber Cancer Institute

1 April 2025

Contact a study center
Step 1 Get in touch with the nearest study center
We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Investigator Avatar

Primary Contact

  Other languages supported:

First name*
Last name*
Email*
Phone number*
Race
Ethnicity
Other language

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.